REARRANGEMENTS OF THE TAL-1 LOCUS AS CLONAL MARKERS FOR T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA

Normal and aberrant immune receptor gene assembly each produce site-specific DNA rearrangements in leukemic lymphoblasts. In either case, these rearrangements provide useful clonal markers for the leukemias in question. In the t(1;14)(p34;q11) translocation associated with T cell acute lymphoblastic leukemia (T-ALL), the breakpoints on chromosome 1 interrupt the tal-1 gene. A site-specific deletion interrupts the same gene in an additional 26% of T-ALL. Thus, nearly one-third of these leukemias contain clustered rearrangements of the tal-1 locus. To test whether these rearrangements can serve as markers for residual disease, we monitored four patients with T-ALL; three of the leukemias contained a deleted (tal(d)) and one a translocated (tal(t)) tal-1 allele. These alleles were recognized by a sensitive amplification/hybridization assay. tal(d) alleles were found in the blood of one patient during the 4th mo of treatment but not thereafter. Using a quantitative assay to measure the fraction of tal(d) alleles in DNA extracts, we estimated that this month 4 sample contained 150 tal(d) copies per 10(6) genome copies. The patient with t(1;14)(p34;q11)(tal(t)) leukemia developed a positive assay during the 20th mo of treatment. By standard criteria, all four patients remain in complete remission 11-20 mo into treatment. We conclude that tal-1 rearrangements provide useful clonal markers for approximately 30% of T-ALLS.